A new class of 5,7-dichloro-1,3-benzoxazole derivatives 4-11 were synthesized by fusing 5,7-dichloro-2-hydrazino-1,3-benzoxazole 3 nucleus with aliphatic acids, active methylene compounds, and with selected esters to form heterocyclic ring systems like 1,2,4-triazoles, pyrazoles, and triazine moieties. e compound 3 on diazotization reaction affords the tetrazole compound. e synthesized compounds were characterized by 1 H NMR, IR, Mass, and 13 C NMR spectral data and screened for cytotoxic, antimicrobial, antioxidant, and antilipase activities. e compounds 4, 5, and 8 have shown signi�cant antimicrobial activities, whereas compounds 6 and 8 have been emerged as leading cytotoxic agents. e compounds 9, 10, and 11 were found to be strong enzyme inhibitors.
Introduction
Wide-spread interest in the chemistry of benzoxazole derivatives in large number of products has attracted the researchers because of their potential applications in medicinal �eld. Benzoxazole derivative constitutes an important class of heterocyclic compounds and shows various types of biological properties such as antiviral, antineoplastic, anti-HIV-1, antitubercular, anthelmintic, antimicrobial, and antifungal activities [1, 2] . In the last few years, 2-substituted benzoxazole derivatives have been studied extensively for their biological importance.
e thiadiazole-containing 1,2,4-triazolo [3,4-b] [1, 3, 4] thiadiazoles were seldom reported with biological activity. e chemistry of triazoles and their derivatives has always been highlighted in study of lead compound discovery study of their variety of biological activities including antifungal, antibacterial, antitubercular, anticancer, and analgesic activities [3] [4] [5] [6] [7] [8] [9] [10] . In support for our study, pyrazoles are also an interesting group of compounds, many of which possess broad spectrum of pharmacological properties. e synthetic analogues of pyrazoles have been known to exhibit industrial, agricultural, and biological applications [11] [12] [13] [14] [15] [16] [17] [18] . In the present work, our group is focused on synthesis of dichlorobenzoxazole derivatives to form various fused heterocyclic ring systems like 1,2,4-triazoles, pyrazoles, tetrazole and triazine moieties with benzoxazole nucleus and screened for some selected biological activities.
Experimental Section
2.1. Chemistry. Melting points were recorded on electrothermal melting point apparatus and are uncorrected.
1 H NMR and 13 C NMR spectra were recorded on Bruker 400 MHz spectrometer in Indian Institute of Science, Bangalore, Karnataka, India. e chemical shis are shown in values (ppm) with tetramethylsilane (TMS) as an internal standard. LC-MS were obtained using C 18 column on Shimadzu, LCMS 2010A, Japan. e Fourier Transform Infrared (FT-IR) spectra of the compounds were taken in KBr pellet (100 mg) using Shimadzu (FT-IR) spectrophotometer. e elemental analysis was carried out using VarioMICROV1.7.0 (Elemental Analysersysteme GmbH) instrument. e column chromatography was performed using silica gel (230-400 mesh). Silica gel GF254 plates from Merck were used for TLC and spots located either by UV or dipping in potassium permanganate solution. e chemicals were purchased from Sigma-Aldrich Co. and from SD Fine Chemicals. e solvents for column chromatography were of reagent grade and were purchased from commercial source. e yields are of puri�ed compounds and are not optimized. e yield, melting point, molecular formula, and molecular weight of the compounds were recorded in Table 1 .
Preparation of 5,7-Dichloro-1,3-benzoxazole-2-thiol (1).
Methanol (50 mL) and potassium hydroxide (1.1eq) were stirred for 10 min and followed by slow addition of carbon disulphide (1.1eq) at room temperature. To the reaction mass, 2-amino-4,6-dichlorophenol (1.eq) was added with stirring. e reaction mass was re�uxed for 6 hr on water bath. e completion of the reaction was monitored by TLC. e reaction mass was poured on to ice cold water and acidi�ed with glacial acetic acid (pH 6). e obtained solid was �ltered, dried, and recrystallized using ethanol. Yield (95%), M.P. 198-199 ∘ C.
Preparation of 5,7-Dichloro-2-(ethylthio)-1,3-benzoxazole (2).
To a mixture of sodium hydroxide (10 mmol) and compound 1 (10 mmol) in di-methyl sulphoxide (10 mL), ethyl iodide (10 mmol) was added dropwise. e reaction mass was stirred about 1 hr, and the completion of the reaction was con�rmed by TLC. e reaction mass was poured on to ice cold water, �ltered the obtained solid, dried, and recrystallized using hexane. [1, 2, 4] triazolo [3,4-b] [1, 3] benzoxazole (4) . e mixture of compound 3 (10 mmol), formic acid (10 mL), and catalytic amount of concentrated hydrochloric acid was heated under re�ux for 5 hr. e reaction mixture was allowed to cool to room temperature and poured onto water (50 mL). e obtained solid was �ltered, washed with ethanol, dried, and recrystallized using methanol.
Preparation of 6,8-Dichloro
Half white solid; IR (KBr) cm [1, 2, 4] triazolo [3,4-b] [1, 3] benzoxazole (5) . e compound 3 (10 mmol) was dissolved in glacial acetic acid (20 mL) and stirred under re�ux for 10 hr. e reaction mixture was allowed to cool to room temperature and poured onto water (50 mL). e solid thus formed was collected by �ltration. e crude solid was washed with ethanol (20 mL), dried, and recrystallized from methanol.
Buff color solid; IR (KBr) cm [5,1-b] [1, 3] benzoxazole (6) . A solution of sodium nitrite (1.04 g, 15 mmol) in 10 mL of water was added dropwise to an ice cold solution of compound 3 (10 mmol) in acetic acid (10 mL). e reaction mixture was kept for stirring about an hour on ice bath at −5 ∘ C. e reaction mixture was allowed to stand for overnight at room temperature. en, it was poured onto water (100 mL). e solid precipitated was �ltered off and crystallized from methanol. (7) . e compound 3 (10 mmol) and ethyl acetoacetate (0,7 g, 10 mmol) mixture was stirred under re�ux in absolute ethanol (30 mL) for 8 hr. e reaction mixture was allowed to cool to room temperature, poured onto cold water (50 mL). e precipitate was �ltered off, dried, and crystallized from methanol.
Preparation of 5,7-Dichlorotetrazolo

Preparation of 2-(5,7-
Light brown color solid; IR (KBr) cm 
Preparation of 5-Amino-2-(5,7-dichloro-1,3-benzoxazol-2-yl)-2,4-dihydro-3H-pyrazol-3-one (8).
To a freshly prepared warmed ethanolic sodium ethoxide solution, compound 3 (10 mmol) and ethyl cyanoacetate (1.3 g, 10 mmol) mixture was added. e mixture was stirred under re�ux for 8 hr. e reaction mixture was allowed to cool to room temperature, then poured onto cold water and neutralized with acetic acid. e solid product was �ltered off, washed with water, ethanol, dried, and crystallized from methanol.
Light brown color solid; IR (KBr) cm (9) . e compound 3 (10 mmol) and acetyl acetone (10 mmol) mixture in absolute ethanol (30 mL) was stirred under re�ux for 5 hr. e reaction mixture was allowed to cool at room temperature and poured onto water. e precipitate was �ltered off, dried, and crystallized from methanol.
Preparation of 5,7-Dichloro-2-(3,5-dimethyl-1H-pyrazol-1-yl)-1,3-benzoxazole
Light brown color solid; IR (KBr) cm [1, 2, 4] triazolo [3,4-b] [1, 3] benzoxazol-3(2H)-one (10) . e compound 3 (10 mmol) and Ethyl chloroformate (10 mmol) mixture in ethanol was re�uxed for 3 hr. e reaction mass was cooled to room temperature and �ltered the solid. e obtained solid was recrystallized using methanol.
Preparation of 6,8-Dichloro
Half white color solid; IR (KBr) cm [1, 2, 4] triazine [3,4-b] [1, 3] benzoxazole-3,4-dione (11) . e compound 3 (10 mmol) and diethyl oxalate (10 mmol) were dissolved in ethanol (20 mL) and re�uxed for 3 hr. e reaction mass was cooled to room temperature and �ltered the solid. e obtained solid was recrystallized using methanol.
Preparation of 7,9-Dichloro-2H-
Half white color solid; IR (KBr) cm [19] . e 24 hr old Muller-Hinton broth cultures of test bacteria were swabbed on sterile Muller-Hinton agar plates using sterile cotton swab followed by punching wells of 6 mm with the help of sterile cork borer. e standard drug (Chloramphenicol, 1 mg/mL of sterile distilled water), compounds 4-11 (20 mg/mL of 10% DMSO), and control (10% DMSO) were added to, respectively, labeled wells. e plates were allowed to stand for 30 minutes and incubated at 37 ∘ C for 24 hr in upright position, and the zone of inhibition was recorded.
Minimum Inhibitory Concentration (MIC).
MIC was determined by micro-dilution method using serially diluted compounds (0 to 20000 g/mL) in nutrient broth tubes. e standardized 0.1 mL of inoculum (10 7 CFU/mL) of test bacteria was added to each tube and incubated at 37 ∘ C for 24 hr. Two control tubes were maintained for each organism. e 4 Journal of Chemistry lowest concentration (highest dilution) of the compounds that produced no visible growth when compared with the control tubes was regarded as MIC [20] .
Antioxidant
Activity. DPPH Assay. e radical scavenging ability of synthesized compounds and the ascorbic acid (standard) was tested on the basis of radical scavenging effect on DPPH free radical. Different concentrations (25, 50, 100, 200, and 400 g/mL) of compounds and standard were prepared in methanol. In clean and labeled test tubes, 2 mL of DPPH solution (0.002% in methanol) was mixed with 2 mL of different concentrations of compounds and standard separately. e tubes were incubated at room temperature in dark for 30 minutes and the optical density was measured at 517 nm using UV-visible spectrophotometer. e absorbance of the DPPH control was also noted. e scavenging activity was calculated using the formula: Scavenging activity (%) = , where is the absorbance of DPPH and is the absorbance of DPPH in standard combination [21] .
Ferric Reducing Assay. Different concentrations (25, 50, 100, 200 and 400 g/mL) of compounds and standard (tannic acid) in 1 mL of methanol were mixed in separate tubes with 2.5 mL of phosphate buffer (200 mM, pH 6.6) and 2.5 mL of 1% potassium ferricyanide. e tubes were placed in water bath for 20 minutes at 50 ∘ C, cooled rapidly, and mixed with 2.5 mL of 10% trichloroacetic acid and 0.5 mL of 0.1% ferric chloride. e amount of iron (II)-ferricyanide complex formed was determined by measuring the formation of Perl's Prussian blue at 700 nm aer 10 minutes. e increase in absorbance of the reaction mixture indicated the increased reducing power [22] .
Pancreatic Lipase Inhibitory Activity.
Extraction of Lipase from Chicken (Gallus domesticus)
Pancreas. Pancreas of freshly slaughtered chicken were collected, washed, and placed in ice cold sucrose solution (0.01 M). e pancreas was homogenized in 0.01 M sucrose, centrifuged. e supernatant liquid was separated and subjected to ammonium sulphate precipitation (50% saturation). e pellet obtained aer centrifugation was dissolved in sucrose solution and again saturated with 50% ammonium sulphate and centrifuged. e pellet obtained was dissolved in phosphate buffer and used as enzyme source [23] .
Determination of Chicken Pancreatic Lipase Activity. e activity of lipase was determined by incubating an emulsion containing 8 mL of olive oil, 0.4 mL of phosphate buffer, and 1 mL of chicken pancreatic lipase for 1 hr in rotary shaker, followed by stopping the reaction by the addition of 1.5 mL of a solution containing acetone and 95% ethanol (1 : 1). e liberated fatty acids were determined by titrating the solution against 0.02 M NaOH (standardized by 0.01 M oxalic acid) using phenolphthalein as an indicator [24, 25] .
Lipase Inhibitory Activity. Lipase inhibitory activity of different concentrations of synthesized compounds (2.5, 5, 10, and 20 mg/mL) was tested by mixing 100 L of each compound, 8 mL of oil emulsion, and 1 mL of chicken pancreatic lipase followed by incubation for 60 minutes. e reaction was stopped by adding 1.5 mL of a solution containing acetone and 95% ethanol (1 : 1). e liberated fatty acids were determined by titrating the solution against 0.02 M NaOH using phenolphthalein as an indicator [26] . e orlistat was used as standard lipase inhibitor, and the percentage inhibition of lipase activity was calculated using the formula:
Lipase inhibition = , where is lipase activity, and is activity of lipase when incubated with the compounds.
Cytotoxic
Activity. e brine shrimp lethality test was conducted to determine cytotoxic activity of compounds [27] . Brine shrimp Artemianauplii eggs (Nihon Animal Pharmaceutical Inc., Tokyo, Japan) were hatched in a container �lled with air-bubbled arti�cial sea water, which was prepared with 10 gm of a commercial salt mixture (GEX Inc., Osaka, Japan) and 500 mL of distilled water. Aer 36-48 hr, the phototropic shrimps were collected by pipette for bioassay. Twenty-�ve shrimps were transferred to each vial containing different concentrations of compounds. e arti�cial sea water was added to make up to 5 mL and incubated at 25 ∘ C, and survived shrimps were counted microscopically in the stem of the pipette against a lightened background aer 24 hr.
Results and Discussion
3.1.
Chemistry. e compound 5,7-dichloro-2-(ethylthio)-1,3-benzoxazole 2 was treated with hydrazine hydrate to afford 5,7-dichloro-2-hydrazino-1,3-benzoxazole 3. e compound 3 was reported in another route [28] , but it is possible to synthesize the intermediate by direct method (Scheme 1). e compound 3 was characterized by H NMR, which exhibited two singlets at 4.6, 9.3 for -NH 2 and -NH protons, respectively (D 2 O exchangeable). e compound 3 on treatment with different reagents gives compounds 4-11 (Scheme 2).
e compound 3 on reacting with aliphatic acids like formic acid and acetic acid afforded 6,8-dichloro [1, 2, 4] triazolo [3,4-b] [1, 3] benzoxazole derivative 4 and 5, respectively. In H NMR, the presence of -CH 3 at 1.9 con�rmed the formation of compound, 5 whereas it did not appear in compound 4. e compound 4 shows a singlet at 12.18 for triazole proton. e compound 3 reacted with nitrous acid in presence of acetic acid yielded 5,7-dichlorotetrazolo[5,1-b][1,3]benzoxazole 6, the formation of tetrazole was con�rmed by the absence of -NH and -NH2 protons and the presence of only two aromatic protons at 7.2 and 7.39. e compound 2-(5,7-dichloro-1,3-benzoxazol-2-yl)-5-methyl-2,4-dihydro-3H-pyrazol-3-one 7 was formed by the reaction between compound 3 and ethyl acetoacetate.
e ethyl cyanoacetate treated with compound 3 yields 5-amino-2-(5,7-dichloro-1,3-benzoxazol-2-yl)-2,4-dihydro-3H-pyrazol-3-one 8. On the other hand, 5,7-dichloro-2-hydrazino-1,3-benzoxazole 3 was condensed with acetyl acetone to form 5,7-dichloro-2-(3,5-dimethyl-1H-pyrazol-1-yl)-1,3-benzoxazole 9 in excellent yield. Two singlets S 2: Synthesis of compounds 4-11. i: HCOOH, ii: CH 3 COOH, iii: NaNO 2 /AcOH, iv:
for six protons at 3.0�3.04 con�rmed the formation of compound 9. e compound 3 was cyclized with ethyl chloroformate and with diethyl oxalate furnished 6,8-dichloro [1, 2, 4] Table 2 . In the antibacterial study, the compounds have shown inhibition of test bacteria. Among synthesized compounds, marked inhibition of test bacteria was observed to compounds 4, 5, and 8, while least activity was observed to compounds 7 and 9.
Minimum inhibitory concentration of synthesized compounds against test bacteria ranged from 250 g/mL to 7500 g/mL. e compounds 4, 5, and 8 caused high inhibition at low concentration and are reported in Table 3 . Figure 1 explains antioxidant activity at different concentrations of compounds 4-11 in methanol and ascorbic acid in terms of free radical scavenging ability which was evaluated using DPPH free radical assay. e compounds exhibited marked antioxidant activity by scavenging DPPH * (free radical) and converting into DPPH, and the activity was found to be dose dependent. e compound 5 was shown to be more potent than ascorbic acid, and results were tabulated in Table 4 .
e result of reducing power at different concentrations of compounds 4-11 and tannic acid is represented in Table 5 . In this study, the absorbance was found to be increased with the dose of compounds and standard, which is suggestive reducing power (Figure 2) . e compounds 4, 6, 7, and 11 showed remarkable reducing power.
Inhibitory activity on chicken pancreatic lipase at different concentrations of compounds in DMSO was determined using olive oil as the substrate. It was found that, the activity of lipase was affected when incubated with the compounds. e inhibitory activity was found to be dose dependent that is, higher inhibition of enzyme was observed on increasing the concentrations of compounds (Figure 3 ). Lipase inhibition was more in case of compound 11. e results are tabulated in Table 6 . e degree of lethality was found to be directly proportional to the concentration of the compounds. e highest mortality was observed at 1000 g/mL concentration of compounds. e most potent activity was observed in case of compounds 6 and 8, whereas the mortality was 100% at the lowest concentration of compounds (Figure 4 of compound 5, 10, and 11 was found to be 896.05, 22.85, and 31.99 g/mL, respectively, and the LC 50 values were determined by linear regression using Origin 6.0 soware. e results are mentioned in Table 7 .
Conclusion
is study reports the successful synthesis of the title compounds via different routes in good yield. e target molecules were characterized and con�rmed by 1 H NMR, IR, Mass, and 13 C NMR spectral analysis and screened for selected biological activities. e compounds 4, 5, and 8 showed marked antibacterial activity, and compounds 10 and 11 exhibited potent pancreas lipase inhibitors, whereas compound 5 acted as scavengers and reducing agents. e compounds 6 and 8 showed potent cytotoxic activity. So, the derivatives of 5,7-dichloro-2-hydrazino-1,3-benzoxazole 3 were found to be biologically potent-fused heterocycles. 
